SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Bayer AG (ADR)(OTCMKTS:BAYRY) has been in a strong downtrend since the beginning of the year. The stock has been forming lower lows and lower highs, pointing towards the strong bearish momentum as bears use every rally in the stock as a selling opportunity. The stock is currently finding resistance at its 50 day moving average. The relative strength index for the stock has given a sell signal considered to be a bearish sign. The momentum indicators are clearly indicating a shift towards the sell side, which is a cause for concern. Traders believe the stock could head to levels of $127.5 in the near term.

b

Bayer AG (ADR)(OTCMKTS:BAYRY) looks forward to increasing its presence in Nursery and Greenhouse markets in the coming year. The announcement was made by Environmental Science, a division of Bayer CropScience.

As per the reports, the company announced that its North American turf and ornamentals would move to make the best use of prevailing production ornamentals market, starting from November 1, 2016. With this shift, Bayer T&O business will be able to offer its services to hundreds of thousands of professional growers in nurseries, greenhouses and many other garden centers across the country.

Road Ahead      

To make the road easy and hassle-free, Bayer will actively market all of its products and ingredients that were earlier marketed by OHP Inc. and other Bayer chemistries. The senior management of the company believes that this step will help the company strengthen its roots in other markets as well. According to Gilles Galliou, President, Bayer Environmental Science North America, OHP has been associated with Bayer for over 26 years. Going forward, Bayer looks forward to interacting with its customers directly to eliminate any communication gap.

Since last many decades, Bayer has been actively serving people in innovative chemistry and ornamentals market. In the future also, it will try its best to live up to everyone’s expectations and enhance the level of servicing to make them feel at ease. Although Bayer has decided to part ways with OHP Inc., both of them will work together to solve many other problems throughout the transition period that might prolong upto one year.

This change in relation won’t put any adverse impact on the relation that both the organizations have been sharing over the last two and a half decades. All those users who want to know more about the upcoming projects of Bayer Inc., can browse its official website and resolve their doubts.